Phase III Data Reaffirms Tezepelumab’s Potential for Severe Asthma
PharmaLive,
New Published: Sept. 7, 2021 By BioSpace Editorial Staff Tezepelumab is showing potential as a new biological therapy for…
New Published: Sept. 7, 2021 By BioSpace Editorial Staff Tezepelumab is showing potential as a new biological therapy for…
Al Seib / Los Angeles Times via Tezepelumab is showing potential as a new biological therapy for severe refractory asthma.